ALVR - Kirby McInerney LLP Reminds AlloVir Inc. (ALVR) Investors of Class Action Filing and Encourages Investors to Contact the Firm | Benzinga

NEW YORK, Feb. 02, 2024 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP reminds investors that a class action lawsuit has been filed in the U.S. District Court for the Massachusetts on behalf of those who acquired AlloVir, Inc. ("AlloVir" or the "Company") (NASDAQ:ALVR) securities during the period of March 22, 2022 through December 21, 2023, inclusive ("the Class Period"). Investors have until March 19, 2024 to apply to the Court to be appointed as lead plaintiff in the lawsuit.

[Click here to learn more about the class action]

In March 2022, AlloVir initiated global phase 3 registrational studies of its lead product posoleucel for the prevention of life-threatening viral infections from viruses in high-risk, ...

ALVR) Investors of Class Action Filing and Encourages Investors to Contact the Firm>Full story available on Benzinga.com